60%
Finnrick rating
#3 of 183 Tirzepatide vendors
0 of 5 classifiable tests passed
natural 0% · customers 4.1★ (2)
methodology · Purity focus
methodology →
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatideselected
$0.35
60%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%10 Jul 2026: 76%10 Jul 2026: 72%10 Jul 2026: 68%10 Jul 2026: 63%20 Jul 2026: 59%2 Aug 2026: current 60%76%59%60%Jul 26Aug 26
Showing Tirzepatide tests only
Syhth Peptide Tirzepatide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
20 Jul 2026Fail
Tested
lab nameView COA
10 Jul 2026Fail
Tested
lab nameView COA
10 Jul 2026Fail
Tested
lab nameView COA
10 Jul 2026Fail
Tested
lab nameView COA
10 Jul 2026Fail
Tested
lab nameView COA

About Syhth Peptide test results from Finnrick

Syhth Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 5 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Syhth Peptide peptides in this dataset are Tirzepatide (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 5 recent tests.

Corrections
No corrections.